Literature DB >> 15931350

The promise of molecular profiling for cancer identification and treatment.

Deanna Cross1, James K Burmester.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15931350      PMCID： PMC1069086          DOI： 10.3121/cmr.2.3.147

Source DB:  PubMed          Journal:  Clin Med Res        ISSN： 1539-4182


× No keyword cloud information.
  19 in total

1.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

Authors:  Izidore S Lossos; Debra K Czerwinski; Ash A Alizadeh; Mark A Wechser; Rob Tibshirani; David Botstein; Ronald Levy
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

2.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

3.  Prognostically useful gene-expression profiles in acute myeloid leukemia.

Authors:  Peter J M Valk; Roel G W Verhaak; M Antoinette Beijen; Claudia A J Erpelinck; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Judith M Boer; H Berna Beverloo; Michael J Moorhouse; Peter J van der Spek; Bob Löwenberg; Ruud Delwel
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

4.  Molecular signatures in biopsy specimens of lung cancer.

Authors:  Alain C Borczuk; Lori Shah; Gregory D N Pearson; Kristin L Walter; Liqun Wang; John H M Austin; Richard A Friedman; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2004-04-15       Impact factor: 21.405

5.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Authors:  Lars Bullinger; Konstanze Döhner; Eric Bair; Stefan Fröhling; Richard F Schlenk; Robert Tibshirani; Hartmut Döhner; Jonathan R Pollack
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

6.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  A molecular signature of the Nottingham prognostic index in breast cancer.

Authors:  Kun Yu; Chee How Lee; Puay Hoon Tan; Ga Sze Hong; Siew Bok Wee; Chow Yin Wong; Patrick Tan
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

8.  Semi-supervised methods to predict patient survival from gene expression data.

Authors:  Eric Bair; Robert Tibshirani
Journal:  PLoS Biol       Date:  2004-04-13       Impact factor: 8.029

9.  Prognostic value of different factors in breast carcinoma.

Authors:  Ljiljana Hlupić; Jasminka Jakić-Razumović; Jadranka Bozikov; Marijana Corić; Borislav Belev; Damir Vrbanec
Journal:  Tumori       Date:  2004 Jan-Feb

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029
View more
  2 in total

1.  Comprehensive mutation profiling by next-generation sequencing of effusion fluids from patients with high-grade serous ovarian carcinoma.

Authors:  Ronak H Shah; Sasinya N Scott; A Rose Brannon; Douglas A Levine; Oscar Lin; Michael F Berger
Journal:  Cancer Cytopathol       Date:  2015-02-05       Impact factor: 5.284

2.  Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?

Authors:  Roman Groisberg; Vivek Subbiah
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.